Acorda Therapeutics Presents New Data On Diazepam Nasal Spray At 67th Annual Meeting Of American Epilepsy Society

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that new data from a pharmacokinetics study on Diazepam Nasal Spray found comparable pharmacokinetics (PK) whether the drug was administered during or immediately after a seizure.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC